Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Oleh KoshovyiInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0001-9545-8548
Getter DolgoševInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.
Udhan Wimukthi MeegamaInstitute of Chemistry, Faculty of Science and Technology, University of Tartu, 50411 Tartu, Estonia.
Koit HerodesInstitute of Chemistry, Faculty of Science and Technology, University of Tartu, 50411 Tartu, Estonia.
Yurii HrytsykDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 76018 Ivano-Frankivsk, Ukraine.ORCID 0000-0003-3006-290X
Lyubov GrytsykDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 76018 Ivano-Frankivsk, Ukraine.ORCID 0000-0003-0338-1462
Andriy GrytsykDepartment of Pharmaceutical Management, Drug Technology and Pharmacognosy, Ivano-Frankivsk National Medical University, 76018 Ivano-Frankivsk, Ukraine.
Igor KireyevInstitute for Advanced Training of Pharmacy Specialists, The National University of Pharmacy, 61002 Kharkiv, Ukraine.
Jyrki HeinämäkiInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0002-5996-5144
Ain RaalInstitute of Pharmacy, Faculty of Medicine, University of Tartu, Nooruse 1, 50411 Tartu, Estonia.ORCID 0000-0001-8731-7366
Funding
Estonian Research Council PRG1903
6 · The paper itself
Abstract
Vervain (
Indexed as
3D printingamino acidsherb extractneurotropic activityphenolic compoundsVerbena officinalis L.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.